FLURBIPROFEN 0.03-PERCENT FOR THE CONTROL OF INFLAMMATION FOLLOWING CATARACT-EXTRACTION BY PHACOEMULSIFICATION

被引：19

作者：

BLAYDES, JE ^{[1
]}

KELLEY, EP ^{[1
]}

WALT, JG ^{[1
]}

DEGRYSE, RE ^{[1
]}

HARPER, DG ^{[1
]}

NOVACK, GD ^{[1
]}

机构：

[1] BLAYDES CLIN,BLUEFIELD,WV

来源：

JOURNAL OF CATARACT AND REFRACTIVE SURGERY | 1993年 / 19卷 / 04期

关键词：

CATARACT SURGERY; FLUOROPHOTOMETRY; FLURBIPROFEN; INFLAMMATION; PHACOEMULSIFICATION; POSTERIOR CHAMBER INTRAOCULAR LENS;

D O I：

10.1016/S0886-3350(13)80611-6

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

We conducted a double-masked, vehicle-controlled study to evaluate the anti-inflammatory effect of topical flurbiprofen in cataract surgery by phacoemulsification and implantation of a posterior chamber intraocular lens. The 233 patients were randomized to receive either flurbiprofen or vehicle immediately prior to and for two weeks following surgery. No concomitant corticosteroid use was allowed. The flurbiprofen group had significantly less anterior chamber cells and flare at day 7 and significantly less conjunctival erythema, corneal edema, and lid edema at day 14. The investigator's global effectiveness rating was higher in the flurbiprofen group at day 14. Blood-aqueous barrier disruption, as measured by aqueous fluorophotometry, was statistically significantly diminished in the flurbiprofen group. Burning and stinging were rated significantly greater in the flurbiprofen group than in the vehicle group. Foreign-body sensation and photophobia were significantly more severe in the vehicle group than in the flurbiprofen group. Flurbiprofen provided postsurgical anti-inflammatory efficacy in clinical signs of inflammation and in blood-aqueous barrier disruption, and also showed improved subjective signs.

引用

页码：481 / 487

页数：7

共 27 条

[1]

Sawa M, Araie M, Tanishima T, A fluorophotometric study of the barrier functions in the anterior segment of the eye after intracapsular cataract extraction, Jpn J Ophthalmol, 27, pp. 404-415, (1983)

[2]

Araie M, Sawa M, Takase M, Topical flurbiprofen and diclofenac suppress blood-aqueous barrier breakdown in cataract surgery: a fluorophotometric study, Jpn J Ophthalmol, 27, pp. 535-542, (1983)

[3]

Miyake K, Asakura M, Maekubo K, Consensual reactions of human blood-aqueous barrier to implant operations, Arch Ophthalmol, 102, pp. 558-561, (1984)

[4]

Sanders DR, Kraff MC, Lieberman HL, Et al., Breakdown and reestablishment of blood-aqueous barrier with implant surgery, Arch Ophthalmol, 100, pp. 588-590, (1982)

[5]

Bizzotto MF, De Franco I, Carillio F, Efficacy of flurbiprofen versus placebo on postoperative course following cataract extraction, Drugs Exptl Clin Res, 10, pp. 421-425, (1984)

[6]

Sabiston D, Tessler H, Sumers K, Et al., Reduction of inflammation following cataract surgery by the nonsteroidal anti-inflammatory drug, flurbiprofen, Ophthalmic Surg, 18, pp. 873-877, (1987)

[7]

Araie M, Takase M, Effects of S-596 and carteolol, new beta-adrenergic blockers, and flurbiprofen on the human eye: a fluorophotometric study, Graefes Arch Clin Exp Ophthalmol, 222, pp. 259-262, (1985)

[8]

Flach AJ, Graham J, Kruger LP, Et al., Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution: a double-masked, paired comparison with vehicle-placebo solution study, Arch Ophthalmol, 106, pp. 344-347, (1988)

[9]

Flach AJ, Kraff MC, Sanders DR, Tanenbaum L, The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1 % dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier, Arch Ophthalmol, 106, pp. 480-483, (1988)

[10]

Kraff MC, Sanders DR, McGuigan L, Raanan MG, Inhibition of blood-aqueous humor barrier breakdown with diclofenac: a fluorophotometric study, Arch Ophthalmol, 108, pp. 380-383, (1990)

← 1 2 3 →